Characterising individuals with a substance use disorder accessing hospital-based addiction care: Preliminary description of the outcomes for patients accessing addiction care prospective cohort study
James H, Morgan J, Nolan S. Drug Alcohol Rev. 2024
Examen de l’association entre les dépenses des unités de santé publique et la consommation de substances chez les adolescents
Rai U, Patte KA, Smith BT, Senthilselvan A, Hyshka E, Leatherdale ST, Pabayo R., Heliyon, 2024
Homes of substance: Drugs and the making of home/lessness for 2S/LGBTQ+ youth
Goodyear T, Jenkins E, Fast D, Oliffe JL, Kia H, Katriana I, Knight R., Soc Sci Med. 2024
2S/LGBTQ+ youth substance use and pathways to homelessness: A photovoice study
Goodyear T, Jenkins E, Oliffe JL, Fast D, Kia H, Knight R., Int J Drug Policy. 2024
Repurposing prescribed hydromorphone: Alternative uses of safer supply and tablet-injectable opioid agonist treatment to meet unaddressed health needs
Ivsins A, Bowles JM, Mansoor M, Kerr T, Bardwell G., Int J Drug Policy. 2024
Characterising methamphetamine/amphetamine use among opioid agonist therapy-seeking adults with prescription-type opioid use disorder in Canada
Langlois J, Fairbairn N, Jutras-Aswad D, Le Foll B, Lim R, Socías ME., Drug Alcohol Rev. 2024
Safer supply and political interference in medical practice: Alberta’s Narcotics Transition Services
Wilson P, Colizza K, Hyshka E., Int J Drug Policy., 2024
Ce que les psychiatres devraient savoir à propos d’un approvisionnement en opioïdes plus sécuritaire sur ordonnance
Bahji A, Danilewitz M, Sachdev A, Mathew N, Lamba W, Rafizadeh R, Chopra N, Dhaliwal A, George TP, Crockford D, Primeau V, Tibbo P, Buckley L, Tanguay R., Can J Psychiatry., 2024
Comment les expériences de stigmatisation et de discrimination à différents moments du parcours de la vie queer s’interagissent avec la consommation d’alcool : points de vue de jeunes à la diversité sexuelle et de genre
Flores-Aranda J, Gaudette Y, Dalle A, Nadeau D, Goyette M. Int J Environ Res Public Health. 2024
Impact of baseline methamphetamine/amphetamine use on discontinuation of methadone and buprenorphine/naloxone among people with prescription-type opioid use disorder in Canada
Langlois J, Fairbairn N, Jutras-Aswad D, Le Foll B, Lim R, Socías ME., Am J Addict. 2024
